Five-year optical coherence tomography follow-up of an everolimus-eluting bioresorbable vascular scaffold: Changing the paradigm of coronary stenting?

Circulation

Volumn 126, Issue 7, 2012, Pages

  Karanasos, Antonios ^a   Simsek, Cihan ^a   Serruys, Patrick ^a   Ligthart, Jurgen ^a   Witberg, Karen ^a   Van Geuns, Robert Jan ^a   Sianos, George ^a   Zijlstra, Felix ^a   Regar, Evelyn ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID PLUS CLOPIDOGREL; ATORVASTATIN; CHOLESTEROL; EVEROLIMUS; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN;

ADULT; ANGIOCARDIOGRAPHY; ARTICLE; CASE REPORT; CORONARY STENT; DRUG ELUTING STENT; FOLLOW UP; HUMAN; MALE; OPTICAL COHERENCE TOMOGRAPHY; PRIORITY JOURNAL; STABLE ANGINA PECTORIS;

ANGINA, STABLE; BIOCOMPATIBLE MATERIALS; CORONARY ARTERY DISEASE; DRUG-ELUTING STENTS; FOLLOW-UP STUDIES; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; SIROLIMUS; TOMOGRAPHY, OPTICAL COHERENCE;

EID: 84865264370     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.112.110122     Document Type: Article

References (3)

1. Serruys PW, Ormiston JA, Onuma Y, Regar E, Gonzalo N, Garcia-Garcia HM, Nieman K, Bruining N, Dorange C, Miquel-Hebert K, Veldhof S, Webster M, Thuesen L, Dudek D. A bioabsorbable everolimus-eluting coronary stent system (ABSORB): 2-year outcomes and results from multiple imaging methods. Lancet. 2009;373:897-910.
2. Onuma Y, Serruys PW, Perkins LE, Okamura T, Gonzalo N, Garcia-Garcia HM, Regar E, Kamberi M, Powers JC, Rapoza R, van Beusekom H, van der Giessen W, Virmani R. Intracoronary optical coherence tomography and histology at 1 month and 2, 3, and 4 years after implantation of everolimus-eluting bioresorbable vascular scaffolds in a porcine coronary artery model: an attempt to decipher the human optical coherence tomography images in the ABSORB trial. Circulation. 2010; 122:2288-2300.
3. Virmani R, Burke AP, Farb A, Kolodgie FD. Pathology of the vulnerable plaque. J Am Coll Cardiol. 2006;47:C13-C18.